is tirzepatide a glp-1 or 2 Management of type diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: systematic review and meta-analysis | Diabetologia Tirzepatide (60mg) - theragenetics

The injectable liquid format is recommended to be administered once every three days, following precise dosage guidelines, helping you achieve visible results with consistent use

When to seek medical help Contact your GP or prescriber or seek urgent medical help if you experience any of the following: Pancreatitis : severe stomach pain that won't go away, with or without nausea or vomiting

Versus other triple/multi-agonists in development : survodutide (GLP-1/GCGR Boehringer Ingelheim), mazdutide (GLP-1/GCGR Eli Lilly), orforglipron (oral non-peptide GLP-1 Eli Lilly), HRS9531 (GLP-1/GIP Hengrui): each represents a distinct signaling architecture

Additionally, incorporating hydrating foods such as cucumbers, watermelon, and leafy greens into your diet can contribute to your overall fluid intake